← Back to Search

Orthosis

Knee Brace for Knee Osteoarthritis

N/A
Recruiting
Led By Edith Martin, Phd. metallurgical engineering
Research Sponsored by TOPMED
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Suffering from medial gonarthrosis
Be older than 18 years old
Must not have
Suffering from tricompartmental gonarthosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up before intervention begins and after 8 weeks of intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking to test a new custom knee brace for treating symptoms of knee osteoarthritis. The aging population is increasing, leading to more people suffering from chronic diseases like osteoarthritis

Who is the study for?
This trial is for individuals with knee osteoarthritis, a common joint condition that causes pain and stiffness. Participants should be seeking treatment to improve their daily activities limited by this chronic disease. Specific eligibility criteria are not provided.
What is being tested?
The study is testing the effectiveness of a custom knee orthosis designed by O3D Inc., which aims to alleviate symptoms of knee gonarthrosis (osteoarthritis) by compensating for biomechanical deficits in patients.
What are the potential side effects?
Potential side effects are not detailed in the provided information but may include discomfort, skin irritation, or increased joint pain if the orthosis does not fit properly or fails to relieve stress on the knee.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have arthritis in the inner part of my knee.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have arthritis in all three compartments of my knee.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~before intervention begins and after 8 weeks of intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and before intervention begins and after 8 weeks of intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
WOMAC functional limitation score
WOMAC pain score
WOMAC stiffness score
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: medial gonarthrosisExperimental Treatment1 Intervention
Patients with medial gonarthrosis

Find a Location

Who is running the clinical trial?

O3D inc.UNKNOWN
TOPMEDLead Sponsor
9 Previous Clinical Trials
558 Total Patients Enrolled
Natural Sciences and Engineering Research Council, CanadaOTHER
62 Previous Clinical Trials
3,232 Total Patients Enrolled
Edith Martin, Phd. metallurgical engineeringPrincipal InvestigatorTOPMED
~29 spots leftby Jul 2025